Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overexpression and structure--function analysis of a bioengineered IL-2/IL-6 chimeric lymphokine.

F Rock1, M Everett, M Klein

  • 1Department of Biochemistry, University of Toronto, Ontario, Canada.

Protein Engineering
|September 1, 1992
PubMed
Summary

Researchers engineered a bifunctional lymphokine by combining interleukin-2 (IL-2) and interleukin-6 (IL-6) genes. This novel fusion protein demonstrates dual activity, enhancing both cellular and humoral immune responses for potential therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Highly productive CO<sub>2</sub> hydrogenation to methanol - a tandem catalytic approach via amide intermediates.

Chemical communications (Cambridge, England)·2017
Same author

Use of a copolymer dressing on superficial and partial-thickness burns in a paediatric population.

Journal of wound care·2015
Same author

Phytochrome control of RNA levels in developing pea and mung-bean leaves.

Planta·2013
Same author

Lipoma of the corpus callosum.

The American journal of roentgenology and radium therapy·2010
Same author

Dental OCT.

Optics express·2009
Same author

A comparative study of heavy metal concentration and distribution in deposited street dusts in a large and a small urban area: Birmingham and Coventry, West Midlands, UK.

Environment international·2003

Area of Science:

  • Immunology
  • Molecular Biology
  • Biotechnology

Background:

  • Interleukin-2 (IL-2) is crucial for cellular immunity, while Interleukin-6 (IL-6) modulates humoral responses.
  • Engineering bifunctional lymphokines can create novel immunomodulatory agents.

Purpose of the Study:

  • To synthesize and characterize a novel bifunctional lymphokine combining IL-2 and IL-6.
  • To assess the refolding, stability, and biological activity of the engineered fusion protein.
  • To evaluate the potential therapeutic applications of this dual-action immunomodulator.

Main Methods:

  • A synthetic chimeric IL-2/IL-6 gene was constructed and overexpressed in Escherichia coli.
  • Inclusion bodies were denatured, refolded, and reoxidized; the fusion protein (rIL-2/IL-6) was purified.

Related Experiment Videos

  • A collagen-like spacer allowed for cleavage into functional IL-2 and IL-6 subunits.

    • Main Results:

    • The purified rIL-2/IL-6 fusion protein reacted with specific antisera for both IL-2 and IL-6.
    • Cleaved subunits were correctly reoxidized and retained full activity comparable to native counterparts.
    • Circular dichroism confirmed proper refolding and alpha-helical structures for both cytokine moieties.
    • The chimera exhibited potent IL-2 activity in cell proliferation assays and IL-6 activity in B-cell and hepatocyte function assays.

    Conclusions:

    • The engineered bifunctional lymphokine (rIL-2/IL-6) is stable, biologically active, and possesses dual IL-2 and IL-6 functions.
    • This fusion protein can amplify cellular and humoral immune responses, indicating therapeutic potential.
    • The developed lymphokine may serve as an effective immunomodulator for enhancing host responses, particularly in vaccination strategies.